← FDA Drug Approvals (Drugs@FDA)

RUFINAMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MICRO LABS · Approved 2023-05-15

Drug application

FDA Application #
ANDA216688
Application type
Abbreviated New Drug Application (Generic)
Brand name
RUFINAMIDE
Generic name
RUFINAMIDE
Active ingredients
RUFINAMIDE
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
MICRO LABS
Manufacturer
Micro Labs Limited
First approval
2023-05-15

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown